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Synthesis of the tricyclic core of manzamine A 
Ravindra B. Pathak, Benjamin C. Dobson, Nandita Ghosh, Khalid A. Ageel, 
Madeha Alshawish, Rungroj Saruengkhanphasit and Iain Coldham*  
An efficient synthetic approach to the core structure of the manzamine alkaloids is reported, particularly 
in relation to incorporating a one-carbon unit in ring B from which the aldehyde in ircinal A or the beta-
carboline unit in manzamine A could potentially be generated. The key steps involve a Johnson–Claisen 
rearrangement, enolate alkylation, dithiane alkylation and a stereoselective intramolecular dipolar 
cycloaddition of an azomethine ylide, which provided the desired tricyclic ABC core structure. 
∃+,−./01,2.+(
The alkaloid manzamine A 1 (Fig. 1) was first reported in 1986 
and has a complex pentacyclic ABCDE structure.1 This 
compound, and related alkaloids,2 have attracted much attention 
due to their intricate structures and their reported biological 
activities.3 Several syntheses of manzamine A 1 and ircinal 2 
have been published to date.4 In addition, several approaches to 
the synthesis of the core ring system, especially of the ABC 
ring system, are known.5  
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Our research group has reported the synthesis of the core ring 
system of manzamine A,6 and several simpler analogues.7 Our 
synthetic approach has focused on the formation of rings B and 
C of manzamine A by using an intramolecular dipolar 
cycloaddition reaction of an azomethine ylide.8 The alcohol 39 
was converted to the ester 4 by using a Johnson–Claisen 
rearrangement (Scheme 1). The ester 4 was converted in 5 steps 
to the aldehyde 8. Condensation with N-methyl glycine ethyl 
ester allowed in situ dipolar cycloaddition to give the tricyclic 
compound 9 as a single stereoisomer (stereochemistry verified 
by single crystal X-ray analysis). However, the aldehyde 8 was 
found to be a poor substrate for reaction with other secondary 
amines. Fortunately, the aldehyde 10 (Scheme 2) was amenable 
to reaction with a variety of secondary amines including N-allyl 
glycine ethyl ester, which gave the desired product 11 as the 
major diastereomer. Alternatively, reaction with the primary 
amine glycine ethyl ester gave the tricyclic product 12, 
presumably arising from the W-shaped, rather than S-shaped, 
azomethine ylide. 
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The examples in Schemes 1 and 2 demonstrate that an 
intramolecular dipolar cycloaddition approach to the ABC ring 
system of the manzamine alkaloids is feasible and can provide 
the desired relative stereochemistry at four of the five 
stereocentres. One aspect that we were conscious of relates to 
the need for a strategy that allows the future incorporation of 
the β-carboline moiety. Except for the recent approach by 
Dixon and co-workers, the reported syntheses of manzamine A 
make use of the alkaloid ircinal A (2).4 We were therefore 
interested in developing chemistry that would allow the 
incorporation of a one-carbon unit in ring B that could be 
suitable for conversion to the aldehyde found in ircinal A (and 
hence to manzamine A itself). This paper describes our efforts 
in this area. 
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Several approaches for the synthesis of a suitable precursor 
compound, with an extra carbon atom in ring B were 
investigated. Ideally this one-carbon unit would be introduced 
as part of the sequence of steps for the preparation of the 
aldehyde used in the key intramolecular dipolar cycloaddition 
step. One approach studied was to alter the Johnson–Claisen 
rearrangement using the alcohol 3. Based on a literature 
method,10 the alcohol 3 was heated with 3,3-diethoxyacrylic 
acid ethyl ester in toluene for just 90 min to give an almost 
quantitative yield of the diester 13 (Scheme 3). Reduction of 
the diester 13 gave the diol 14. Treatment of the diol 14 with 
acetic anhydride gave the monoester 15 (and 28% diester) as an 
inseparable mixture of diastereomers. Reaction of the diol 14 
with sodium hydride and TBDPSCl or p-methoxybenzyl 
chloride gave the alcohols 16 or 17 respectively, but these also 
were a 1:1 inseparable mixture of diastereomers. 
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As a possible way to distinguish the hydroxymethyl groups, we 
treated the diol 14 with iodine to give the tetrahydrofuran 18 
(Scheme 4). This did result in some preference for cyclization 
of one of the alcohols, although the selectivity was not high (dr 
3:1 by 1H NMR spectroscopy) and the diastereomers were 
inseparable by column chromatography. Protection of the 
alcohol gave compound 19, but these diastereomers were also 
inseparable. Despite this result, we treated compound 19 with 
zinc, which promoted ring opening to give the mixture (dr 3:1) 
of diastereomeric alcohols 17. Therefore this method is able to 
provide the desired compound 17 with some selectivity (by 1H 
NMR spectroscopy the major isomer was 17a, see below), 
although this was insufficient for further studies.  
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Two further methods to access a single diastereomer of alcohol 
17 were investigated. Following precedent for asymmetric 
hydroxymethylation of aldehydes,11 we treated the aldehyde 
20
6b with proline and aqueous formaldehyde (Scheme 5). 
However, this gave rise not to the desired α-hydroxymethyl 
aldehyde product but rather the alkene 21 resulting from 
elimination. Finally, we performed a simple deprotonation of 
the ester 4 with LDA followed by addition of formaldehyde 
(Scheme 5). This gave a mixture of the alcohols 22 and 23 
which we were delighted to find were separable by careful 
column chromatography. Taking a mixture of these isomers 
through the subsequent chemistry described below gave 
diastereomeric products that in all cases were inseparable from 
each other, so it was important to separate alcohols 22 and 23 at 
this stage. 
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To determine the relative stereochemistry, we took the less 
polar isomer (which turned out to be compound 23, see below) 
and treated it with p-bromobenzoyl chloride to obtain the ester 
24 (Scheme 6). This compound was not crystalline, so the N-
Boc group was removed with acid and the crude amine product 
was protected as the sulfonamide 25. This compound was 
amenable to single crystal X-ray analysis, which showed the 
relative stereochemistry as depicted (Fig. 2). 
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With both single diastereomers 22 and 23 in hand, we selected 
one of these for further study. The less polar isomer 23 was 
protected to give the ether 26 and reduction gave the alcohol 
17a (Scheme 7). Conversion of the alcohol to the iodide 27 and 
displacement with the anion of ethyl 1,3-dithiane-2-carboxylate 
gave the ester 28. This was converted in three steps (reduction, 
transacetalisation, and oxidation) to the aldehyde 31.  
The key step in our synthetic route to the manzamine alkaloids 
involves an intramolecular dipolar cycloaddition with an 
aldehyde tethered to the 4-position of a 3-exomethylene-
piperidine. We therefore heated aldehyde 31 with N-allyl 
glycine ethyl ester (Scheme 8). This gave the desired tricyclic 
product 32 as a single stereoisomer, but only in 20–30% yield. 
The yield did improve (to 38%) by using the hydrochloride salt 
of N-allyl glycine ethyl ester together with iPr2NEt. Other 
conditions (such as using excess amine or higher temperature) 
did not improve the yield. In all cases the product isolated was 
the enol ether 32, in which the cycloadduct had lost methanol. 
It is not clear why this loses methanol in comparison with the 
formation of cycloadduct 11 but sterics may play a part. As an 
alternative, the aldehyde 31 was heated with glycine ethyl ester 
to give the tricyclic product 33. The stereochemistry of these 
cycloadducts is assumed to be as shown, based on related 
chemistry (see Scheme 2).  
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By using the same chemistry as shown in Scheme 7 with a 1:1 
unseparated mixture of the diastereomers 22 and 23, resulted in 
a 1:1 inseparable mixture of the aldehyde 31 and its 
diastereomer. Heating this mixture of stereoisomers with N-
allyl glycine ethyl ester gave the same product 32 in 18% yield 
as the only product that could be isolated. This indicates that 
the stereoisomer derived from the ester 22 does not undergo the 
desired intramolecular dipolar cycloaddition reaction. Analysis 
of the conformations of the stereoisomers of the azomethine 
ylides suggests that a favourable conformation exists from the 
stereoisomer 31 (Fig. 3). The azomethine ylide derived from 
the other diastereomer of 31 would suffer from greater steric 
interactions. This may explain the preference for cycloaddition 
only from diastereomer 31.  
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The successful synthesis of the tricyclic product 32 represents a 
stereoselective approach to the ABC core ring system of the 
manzamine alkaloids. One of the drawbacks of the chemistry 
discussed above is that a 1:1 mixture of the stereoisomers 22 
and 23 is formed and only one of these is suitable for further 
elaboration. We have found that the undesired stereoisomer 22 
can be converted to the desired compound 17a by the sequence 
of reactions shown in Scheme 9. Protection of the alcohol 22 
with methoxymethyl chloride followed by reduction of the ester 
gave the alcohol 35 (Scheme 9). Protection of this alcohol as its 
PMB ether and removal of the MOM group selectively with 
mild acid gave the product 17a. Alternatively, it is possibly to 
simply treat the undesired isomer 22 with sodium ethoxide to 
promote epimerization. The resulting 1:1 mixture of esters 
(quantitative yield) can be separated by column 
chromatography.  
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We have described a short and stereoselective route to prepare 
the ABC tricyclic ring system found in the manzamine 
alkaloids. This extends our previous work by demonstrating 
that a one-carbon unit can be located in ring B. This substituent 
could potentially be used to later generate the aldehyde 
functional group found in ircinal A and hence the beta-
carboline unit in manzamine A. Although a mixture of 
stereoisomers was formed when introducing this one-carbon 
unit, the undesired isomer can be isomerised. The key steps in 
the chemistry involve a Johnson–Claisen [3,3]-sigmatropic 
rearrangement, a dithiane alkylation, and an azomethine ylide 
dipolar cycloaddition. The dipolar cycloaddition was successful 
with only one diastereomer of the starting material. The yield in 
this key step was not particularly high, but the chemistry is 
significant as it demonstrates the importance of the choice of 
stereochemistry in such intramolecular cycloadditions when 
used as part of a synthetic endeavour. 
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tert-Butoxycarbonyl-3-methylene-piperidin-4-yl-malonic 
acid diethyl ester 13 
The alcohol 3 (10.0 g, 46.9 mmol), 3,3-diethoxyacrylic acid 
ethyl ester (17.65 g, 93.8 mmol) and 2,4-dinitrophenol (863 mg, 
4.69 mmol) were heated in toluene (250 mL) at 110 °C. After 
90 min, the solvent was evaporated and the residue was purified 
by column chromatography, eluting with petrol–EtOAc (9:1), 
to give the diester 13 (16.1 g, 97%) as an oil; Rf 0.33 [petrol–
EtOAc 7:3]; νmax (neat)/cm
–1 2965, 2925, 2865, 1725, 1695; 1H 
NMR (500 MHz, CDCl3) δ = 4.89 (1H, br s), 4.71 (1H, s), 4.15 
(2H, q, J 7), 4.12–4.08 (2H, m), 3.94 (1H, br d, J 14), 3.76 (1H, 
d, J 14), 3.62 (1H, d, J 11), 3.53 (1H, ddd, J 13.5, 7.5, 4), 3.36–
3.29 (1H, m), 3.02 (1H, ddd, J 11, 7.5, 4), 1.75–1.67 (1H, m), 
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1.54–1.46 (1H, m), 1.39 (9H, s), 1.22 (3H, t, J 7), 1.18 (3H, t, J 
7); 13C NMR (126 MHz, CDCl3) δ =167.9, 154.5, 142.7, 111.2, 
79.6, 61.5, 61.4, 53.6, 49.3 (br), 41.9 (br), 40.8, 29.5, 28.3, 
14.0; HRMS (ES) Found MNa+ 378.1882. C18H29NO6Na 
requires MNa+ 378.1893; LRMS m/z (ES) 378 (96%), 356 
(4%), 256 (100%). 
 
4-(2-Hydroxy-1-hydroxymethyl-ethyl)-3-methylene-
piperidine-1-carboxylic acid tert-butyl ester 14 
LiAlH4 (18.5 mL, 18.5 mmol, 1.0 solution in THF) was added 
dropwise to the diester 13 (1.64 g, 4.63 mmol) in THF (15 mL) 
at 0 °C. After 1 h, water (10.8 mL) and NaOH (2.8 mL, 4 M) 
were added and the mixture was filtered through celite. The 
solvent was evaporated and the residue was purified by column 
chromatography, eluting with EtOAc, to give the diol 14 (0.80 
g, 64%) as an oil; Rf 0.44 [EtOAc]; νmax (neat)/cm
–1 3395, 
2970, 2930, 1670, 1570; 1H NMR (500 MHz, CDCl3) δ = 4.96 
(1H, br s), 4.82 (1H, s), 3.97–3.86 (2H, m), 3.82–3.64 (4H, m), 
3.52–3.37 (4H, m), 2.43–2.34 (1H, m), 2.06–1.94 (1H, m), 
1.79–1.55 (2H, m), 1.42 (9H, s); 13C NMR (126 MHz, CDCl3) 
δ = 154.9, 143.8, 111.6, 79.8, 64.6, 63.2, 41.1 (br), 40.1, 38.6, 
28.4, 28.3; HRMS (ES) Found MNa+ 294.1675. C14H25NO4Na 
requires MNa+, 294.1681; LRMS m/z (ES) 294 (100%). 
 
4-(2-Acetoxy-1-hydroxymethyl-ethyl)-3-methylene-
piperidine-1-carboxylic acid tert-butyl ester 15 
The diol 14 (0.20 g, 0.73 mmol), Ac2O (0.10 mL, 0.75 mmol), 
pyridine (0.05 mL, 0.74 mmol) and 4-dimethylaminopyridine 
(~10 mg) in CH2Cl2 (10 mL) were stirred at room temperature. 
After 24 h, water (5 mL) was added and the solution was 
extracted with CH2Cl2 (3 × 5 mL). The combined organic layers 
were washed with brine (5 mL), dried (MgSO4), and 
evaporated. The residue was purified by column 
chromatography, eluting with EtOAc, to give the acetate 15 
(0.15 g, 68%) as a mixture of diastereomers (1:1) as an oil; Rf 
0.64 [EtOAc]; νmax (neat)/cm
̼1
 3445, 2950, 1735, 1665; 
1H 
NMR (400 MHz, CDCl3) δ = 4.99 (2H, br s), 4.85 (1H, s), 4.83 
(1H, s), 4.38 (1H, d, J 3.5), 4.35 (1H, d, J 3.5), 4.21 (1H, d, J 
4.5), 4.18 (1H, d, J 4.5), 4.12 (1H, d, J 6.5), 4.09 (1H, d, J 6.5), 
3.96 (1H, d, J 10), 3.93 (1H, d, J 10), 3.80–3.75 (2H, m), 3.74–
3.72 (2H, m), 3.66–3.58 (1H, m), 3.54–3.46 (1H, m), 3.43–3.31 
(2H, m),  2.46–2.36 (2H, m), 2.19–2.08 (4H, m), 2.08 (6H, s), 
1.84–1.72 (2H, m), 1.71–1.62 (2H, m), 1.42 (18H, s); 13C NMR 
(100 MHz, CDCl3) δ = 171.6, 171.5, 154.7, 154.6, 143.8, 143.5, 
111.9, 111.6, 79.7, 79.6, 63.6, 62.3, 61.5, 59.8, 40.8, 39.2, 39.0, 
38.9, 38.7, 28.4, 28.3, 28.2, 20.9; HRMS (ES) found: MH+, 
314.1974. C16H28NO5 requires MH
+, 314.1967; LRMS m/z (ES) 
314 (100%). 
 
4-[1-(tert-Butyl-diphenyl-silanyloxymethyl)-2-hydroxy-
ethyl]-3-methylene-piperidine-1-carboxylic acid tert-butyl 
ester 16 
NaH (220 mg, 5.4 mmol, 60% dispersion in oil) was added to 
the diol 14 (1.39 g, 5.2 mmol) in THF (30 mL) at 0 °C. After 50 
min, tert-butyldiphenylsilyl chloride (1.47 mL, 5.6 mmol) was 
added dropwise. After 1 h, saturated aqueous NaHCO3 (20 mL) 
was added and the mixture was extracted with CH2Cl2 (3 × 20 
mL), dried (MgSO4) and evaporated. Purification by column 
chromatography, eluting with petrol–EtOAc (4:1), gave the 
alcohol 16 (2.59 g, 99%) as a mixture of diastereomers (1:1) as 
an oil; Rf 0.33 [petrol–EtOAc 4:1]; νmax (neat)/cm
–1 3450, 3075, 
2930, 2855, 1690, 1665, 1590; 1H NMR (500 MHz, CDCl3) δ = 
7.68–7.63 (8H, m), 7.46–7.36 (12H, m), 4.92 (1H, s), 4.81 (1H, 
s), 4.75 (1H, s), 4.64 (1H, s), 3.96–3.87 (5H, m), 3.77–3.68 
(7H, m), 3.57 (1H, d, J 14), 3.45–3.32 (3H, m), 3.21–3.14 (1H, 
m), 2.38–2.30 (2H, m), 2.02–1.95 (2H, m), 1.72–1.65 (1H, m), 
1.62–1.52 (2H, m), 1.43 (9H, s), 1.43 (9H, s), 1.06 (9H, s), 1.06 
(9H, s); 13C NMR (126 MHz, CDCl3) δ =154.7, 143.8, 135.6, 
132.9, 129.9, 127.8, 111.6, 79.5, 65.9, 64.2, 63.2, 49.0, 41.3, 
40.8, 40.3, 38.9, 38.6, 28.4, 28.3, 26.9, 19.2; HRMS (ES) 
Found MNa+ 532.2856. C30H43NO4NaSi requires MNa
+ 
532.2859; LRMS m/z (ES) 532 (100%), 510 (6%). 
 
4-[2-hydroxy-1-(4-methoxy-benzyloxymethyl)-ethyl]-3-
methylene-piperidine-1-carboxylic acid tert-butyl ester 17 
NaH (180 mg, 4.48 mmol, 60% dispersion in mineral oil) was 
added to the diol 14 (1.21 g, 4.48 mmol) in THF (20 mL) at 0 
°C. After 50 min, 4-methoxybenzyl chloride (0.67 mL, 4.93 
mmol) and tetrabutylammonium iodide (0.165 g, 4.48 mmol) in 
THF (5 mL) were dropwise. After 3 d, the solvent was 
evaporated and the residue was purified by column 
chromatography, eluting with petrol–EtOAc (1:1), to give the 
alcohol 17 (1.39 g, 80%) as a mixture of diastereomers (1:1) as 
an oil; Rf 0.41 [petrol–EtOAc 1:1]; νmax (neat)/cm
̼1 3450, 3075, 
2970, 2920, 2860, 1680, 1610, 1585; 1H NMR (500 MHz, 
CDCl3) δ = 7.23–7.18 (4H, m), 6.88–6.84 (4H, m), 4.94 (2H, br 
s), 4.81 (1H, s), 4.75 (1H, s), 4.46–4.36 (4H, m), 3.89–3.81 
(4H, m), 3.78 (3H, s), 3.77 (3H, s), 3.74–3.62 (4H, m), 3.58–
3.43 (4H, m), 3.42–3.81 (4H, m), 2.47–2.41 (1H, m), 2.41–2.35 
(1H, m), 2.11–2.02 (2H, m), 1.74–1.61 (2H, m), 1.61–1.59 (1H, 
m), 1.53–1.45 (1H, m), 1.43 (18H, s); 13C NMR (126 MHz, 
CDCl3) δ =163.4, 159.2, 154.7, 143.9, 129.8, 129.7, 129.2, 
113.8, 111.4, 79.5, 73.2, 72.4, 70.5, 64.5, 63.5, 55.2, 49.5, 48.0, 
40.9, 39.3, 38.9, 38.7, 38.5, 28.3, 28.2; HRMS (ES) Found 
MNa+, 414.2257. C22H33NO5Na requires MNa
+, 414.2256; 
LRMS m/z (ES) 414 (100%). 
Alternatively, compound 17a was prepared from 26 by the 
following method: 
LiAlH4 (96 mg, 2.5 mmol) was added to the ester 26 (1.0 g, 2.3 
mmol) in THF (20 mL) at –5 °C. After 40 min, EtOAc (10 mL) 
was added, followed by addition of Na2SO4 until a while salt 
precipitated. The mixture was filtered through celite. The 
solvent was evaporated and the residue was purified by column 
chromatography, eluting with petrol–EtOAc (1:1), to give the 
alcohol 17a (0.63 g, 69%) as an oil; data for single 
stereoisomer: 1H NMR (400 MHz, CDCl3) δ = 7.25 (2H, d, J 
8), 6.90 (2H, d, J 8), 4.97 (1H, s), 4.79 (1H, s), 4.46–4.39 (2H, 
m), 3.97 (1H, d, J 14), 3.89 (1H, dd, J 11, 2), 3.82 (3H, s), 
3.76–3.68 (2H, m), 3.60–3.47 (3H, m), 3.41–3.35 (1H, m), 
2.50–2.45 (1H, m), 2.10–2.06 (1H, m), 1.78–1.62 (2H, m), 1.46 
(9H, s); 13C NMR (126 MHz, CDCl3) δ =159.3, 154.8, 143.8, 
!∀#∃%&∋( ;−4<+21(=(>2.9.?810?<−(%7892≅,−Α(
Ε (Χ(∀#∃%!&∋()(∗%!+,−)?≅(;<=>≅())≅(=ΑΒ( 51&2(6+/∀%∃−(&2(7(51.(8+4∃−(9+∋&.34(+:(01.,&23∀4(;<=>(
129.8, 129.3, 113.9, 111.6, 79.6, 73.3, 72.6, 63.8, 55.3, 48.8 
(br), 40.9, 38.7, 38.5, 28.5, 28.3. 
Alternatively, compound 17a was prepared from 36 by the 
following method: 
Aqueous hydrochloric acid (0.07 mL, 2 M) was added to the 
ether 36 (1.0 g, 2.30 mmol) in dry isopropyl alcohol (10 mL) 
and the mixture was heated at 60 °C. After 7 h, the mixture was 
allowed to cool to room temperature and saturated aqueous 
NaHCO3 solution (20 mL) was added. The mixture was 
extracted with Et2O (3 × 50 mL). The combined organic layers 
were washed with brine (10 mL), dried (MgSO4) and 
evaporated. Purification by column chromatography, eluting 
with petrol–EtOAc (1:1), gave the alcohol 17a (0.61 g, 68%) as 
an oil; data as above. 
 
tert-Butyl 3-(Hydroxymethyl)-7a-(iodomethyl)-
octahydrofuro[2,3-c]pyridine-6-carboxylate 18 
Iodine (1.73 g, 6.83 mmol) in CH2Cl2 (30 mL) was added to the 
diol 14 (1.76 g, 6.50 mmol) in saturated aqueous NaHCO3 (20 
mL) at 0 °C. After 2 h, aqueous Na2SO3 (10 mL) was added 
dropwise. The aqueous layer was separated and was extracted 
with CH2Cl2 (3 × 30 mL). The organic extracts were washed 
with water (20 mL) and brine (20 mL), dried (MgSO4), 
evaporated and purified by column chromatography, eluting 
with EtOAc, to give iodide 18 (1.94 g, 75%) as mixture of 
diastereoisomers (3:1) as an oil; Rf 0.41 (EtOAc); νmax 
(neat)/cm–1 3450, 3310, 2930, 2850, 1695, 1610; 1H NMR (400 
MHz, CDCl3, peaks for major diastereomer listed) δ = 4.09 
(1H, t, J 7), 3.98–3.85 (1H, m), 3.79–3.67 (4H, m), 3.43 (1H, d, 
J 11), 3.35 (1H, d, J 11), 3.08–2.98 (2H, m), 2.55–2.50 (1H, 
m), 2.13–1.92 (2H, m), 1.83–1.70 (2H, m), 1.48 (9H, s); 13C 
NMR (100 MHz, CDCl3, major diastereomer) δ = 154.8, 80.6, 
69.5, 63.5, 60.4, 47.6, 45.0, 43.6, 39.3, 28.4, 24.4, 14.3; HRMS 
(ES) Found MNa+ 420.0631. C14H24NO4INa requires MNa
+ 
420.0648; LRMS m/z (ES) 420 (100%). 
 
tert-Butyl 7a-(Iodomethyl)-3-{[(4-
methoxyphenyl)methoxy]methyl}-octahydrofuro[2,3-
c]pyridine-6-carboxylate 19 
Alcohol 18 (2.14 g, 5.40 mmol) in THF (10 mL) was added via 
cannula to sodium hydride (0.2 g, 8.6 mmol) in THF (20 mL). 
After 30 min, the mixture was cooled to 0 °C and 4–
methoxybenzyl chloride (0.84 mL, 6.21 mmol) in THF (10 mL) 
was added. After 30 min the mixture was allowed to warm to 
room temperature. After 24 h, aqueous sodium chloride 
solution (20 mL) was added. The mixture was extracted with 
Et2O (3 × 20 mL), dried (MgSO4), evaporated and purified by 
column chromatography, eluting with petrol–EtOAc (9:1), to 
give the iodide 19 (2.6 g, 60%) as a mixture of diastereomers 
(3:1) as an oil; Rf 0.51 (petrol–EtOAc 8:2); νmax (neat)/cm
–1 
2850, 1685, 1615, 1595; 1H NMR (400 MHz, CDCl3, peaks for 
major diastereomer listed) δ = 7.25 (2H, d, J 8.5), 6.90 (2H, d, J 
8.5), 4.45 (2H, s), 4.08 (1H, t, J 7.5), 4.10–4.06 (1H, m), 3.83 
(3H, s), 3.69 (1H, t, J 7.5), 3.57–3.47 (2H, m), 3.42 (1H, d, J 
11), 3.32 (1H, d, J 11), 3.04–2.93 (2H, m), 2.62–2.57 (1H, m), 
2.09–2.06 (1H, m), 1.77–1.71 (2H, m), 1.64–1.56 (1H, m), 1.48 
(9H, s); 13C NMR (100 MHz, CDCl3, major diastereomer) δ = 
159.3, 154.7, 130.0, 129.2, 113.9, 80.5, 73.0, 71.0, 69.9, 69.5, 
55.3, 47.3, 44.1, 42.1, 41.6, 28.4, 24.4, 14.4; HRMS (ES) 
Found MH+ 518.1392. C22H32NO5I requires MH
+  518.1404; 
LRMS m/z (ES) 540 (100%, MNa+). 
 
tert-Butyl 4-[2-(1-Oxo-propenyl)]-3-methylidenepiperidine-
1-carboxylate 21 
Aqueous formaldehyde (37%) (0.44 mL, 5.4 mmol) was added 
to the aldehyde 206b (1.0 g, 4.2 mmol) and L-proline (48 mg, 
0.42 mmol) in DMF (5 mL) at room temperature. After 5 h, 
brine (10 mL) was added. The mixture was extracted with 
EtOAc (3 × 20 mL), dried (MgSO4) and evaporated. The 
residue was purified by column chromatography, eluting with 
petrol–EtOAc (4:1), to give the aldehyde 21 (938 mg, 89%) as 
an oil; Rf 0.40 [petrol–EtOAc 4:1]; νmax (neat)/cm
–1 2980, 1685; 
1H NMR (500 MHz, CDCl3) δ = 9.46 (1H, s), 6.21 (1H, s), 6.15 
(1H, s), 4.76 (1H, s), 4.34 (1H, s), 4.31 (1H, br s), 3.97 (1H, br 
s), 3.42 (1H, d, J 13), 3.29 (1H, dd, J 11, 5), 2.97–2.82 (1H, m), 
1.67–1.56 (2H, m), 1.33 (9H, s); 13C NMR (126 MHz, CDCl3) 
δ = 193.4, 154.2, 150.0, 143.4, 135.6, 109.9, 79.4, 49.7 (br), 
43.2, 39.9, 30.5, 28.1; HRMS (ES) Found MH+ 252.1589. 
C14H22NO3 requires MH
+ 252.1600; LRMS m/z (ES) 252 
(27%), 196 (100%). 
 
4-(1-Ethoxycarbonyl-2-hydroxy-ethyl)-3-methylene-
piperidine-1-carboxylic acid tert-butyl ester 22 and 23 
n-BuLi (8.12 mL, 16.2 mmol, 2.0 M in hexanes) was added to 
diisopropylamine (2.45 mL, 17.5 mmol) in THF (50 mL) at 0 
°C. After 30 min the mixture was cooled to –78 °C and the ester 
4 (3.83 g, 13.5 mmol) was added dropwise. After 3.5 h 
formaldehyde (1.22 g, 40.5 mmol) was added and the mixture 
was allowed to warm to room temperature over 16 h. Saturated 
NH4Cl(aq) (50 mL) was added and the mixture was extracted 
with Et2O (4 × 50 mL). The organic layers were washed with 
water, dried (MgSO4) and evaporated. Purification by column 
chromatography, eluting with petrol–EtOAc (3:2), gave a 1:1 
separable mixture of alcohols 22 and 23 (2.66 g, 63%) as oils; 
Data for 22: 
Rf 0.38 [petrol–EtOAc 1:1]; νmax (neat)/cm
–1 3455, 2940, 2875, 
1730, 1690, 1675; 1H NMR (250 MHz, CDCl3) δ = 4.91 (1H, br 
s), 4.79 (1H, s), 4.19–4.07 (2H, m), 3.97 (1H, d, J 14), 3.80–
3.90 (2H, m), 3.59–3.32 (3H, m), 2.91–2.82 (1H, m), 2.80–2.67 
(1H, m), 2.30 (1H, br s), 1.84–1.63 (2H, m), 1.43 (9H, s), 1.23 
(3H, t, J 7); 13C NMR (63 MHz, CDCl3) δ = 174.5, 154.6, 
143.1, 111.1, 79.7, 61.0, 60.6, 48.1, 41.4, 40.0, 28.4, 28.3, 14.1; 
HRMS (ES) Found MH+ 314.1964. C16H28NO5 requires MH
+ 
314.1967; LRMS m/z (ES) 336 (43%), 314 (13%), 258 (100%). 
Data for 23: 
Rf 0.47 [petrol–EtOAc 1:1]; νmax (neat)/cm
–1 3425, 2980, 2935, 
1730, 1695; 1H NMR (500 MHz, CDCl3) δ = 4.91 (1H, br s), 
4.80 (1H, s), 4.15–4.06 (2H, m), 4.00–3.86 (1H, m), 3.68–3.56 
(3H, m), 3.55–3.45 (1H, m), 3.33–3.23 (1H, m), 3.03–2.74 (2H, 
m), 2.55–2.50 (1H, m), 1.68–1.57 (1H, m), 1.48–1.35 (1H, m), 
1.35 (9H, s), 1.21–1.15 (3H, m); 13C NMR (126 MHz, CDCl3) 
δ = 174.2, 154.6, 142.4, 112.5, 79.7, 62.4, 60.7, 48.8 (br), 47.4, 
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40.5, 40.0, 29.6, 28.3, 14.1; HRMS (ES) Found MNa+ 
336.1785. C16H27NO5Na requires MNa
+ 336.1787; LRMS m/z 
(ES) 336 (100%). 
 
4-[2-(4-Bromo-benzoyloxy)-1-ethoxycarbonyl-ethyl]-3-
methylene-piperidine-1-carboxylic acid tert-butyl ester 24 
4-Bromobenzoyl chloride (352 mg, 1.60 mmol), Et3N (0.27 
mL, 1.92 mmol) and DMAP (78 mg, 0.64 mmol) were added to 
the alcohol 22 (more polar diastereomer) (200 mg, 0.64 mmol) 
in CH2Cl2 (10 mL). After 3 h, saturated aqueous NaHCO3 (10 
mL) was added. Extraction with CH2Cl2 (3 × 10 mL), drying 
(MgSO4), and purification by column chromatography, eluting 
with petrol–EtOAc (4:1), gave the ester 24 (313 mg, 99%) as an 
oil; Rf 0.18 [petrol–EtOAc 7:3]; νmax (neat)/cm
–1 3070, 2965, 
2925, 2865, 1725, 1695, 1590; 1H NMR (500 MHz, CDCl3) δ = 
7.82–7.77 (2H, m), 7.54–7.50 (2H, m), 5.01 (1H, br s), 4.92 
(1H, br s), 4.48 (1H, dd, J 10.5, 4), 4.29 (1H, t, J 10.5), 4.15 
(2H, q, J 7), 3.70 (1H, d, J 17), 3.65–3.56 (1H, m), 3.36–3.28 
(1H, m), 3.20–3.14 (1H, m), 2.63 (1H, dt, J 11, 5), 1.77–1.68 
(1H, m), 1.56–1.49 (1H, m), 1.41 (9H, s), 1.18 (3H, t, J 7); 13C 
NMR (126 MHz, CDCl3) δ = 172.7, 165.3, 154.6, 141.9, 131.7, 
131.0, 128.6, 128.3, 113.1, 79.7, 65.1, 60.9, 48.0 (br), 44.7, 
40.5, 39.9 (br), 29.7, 28.3, 14.2; HRMS (ES) Found MH+ 
496.1313. C23H31
79BrNO6 requires MH
+ 496.1335; LRMS m/z 
(ES) 498 (25%), 496 (28%), 442 (92%), 440 (100%), 398 
(65%), 396 (68%). 
 
4-Bromobenzoic acid 2-Ethoxycarbonyl-2-[3-methylene-1-
(toluene-4-sulfonyl)-piperidin-4-yl]-ethyl ester 25 
TFA (0.65, 8.52 mmol) was added to the ester 24 (1.05 g, 2.13 
mmol) in CH2Cl2 (15 mL). After 16 h, further TFA (4.0 mL, 
51.9 mmol) was added. After 2 h, saturated aqueous NaHCO3 
was added until the solution became basic and the mixture was 
extracted with CH2Cl2 (4 × 20 mL). The organic layers were 
combined, dried (MgSO4) and evaporated to give the secondary 
amine as an oil. To this, in CH2Cl2 (10 mL) with Et3N (0.33 
mL, 2.34 mmol) at room temperature, was added tosyl chloride 
(446 mg, 2.34 mmol). After 19 h, water (20 mL) was added and 
the mixture was extracted with EtOAc (3 × 15 mL), washed 
with saturated aqueous NaHCO3 (50 mL) and brine (50 mL), 
dried (MgSO4) and evaporated. Purification by column 
chromatography, eluting with petrol–EtOAc (4:1), followed by 
recrystallisation from EtOAc, gave the ester 25 (729 mg, 62% 
over 2 steps) as needles; m.p. 153–154 °C; Rf  0.35 [petrol–
EtOAc 4:1]; νmax (neat)/cm
–1 2955, 2915, 2855, 1725, 1715, 
1650, 1585, 1340, 1155; 1H NMR (250 MHz, CDCl3) δ = 7.77 
(2H, d, J 8), 7.63 (2H, d, J 8), 7.52 (2H, d, J 8), 7.30 (2H, d, J 
8), 5.12 (1H, br s), 5.02 (1H, br s), 4.40 (1H, dd, J 10.5, 3.5), 
4.28–4.07 (3H, m), 3.73 (1H, d, J 12.5), 3.45–3.23 (2H, m), 
3.07–2.85 (2H, m), 2.64–2.49 (1H, m), 2.42 (3H, s), 1.96–1.74 
(1H, m), 1.72–1.51 (1H, m), 1.18 (3H, t, J 7); 13C NMR (63 
MHz, CDCl3, one C not observed) δ = 172.3, 165.2, 143.7, 
139.8, 133.2, 131.8, 131.0, 129.8, 128.4, 127.7, 114.8, 64.7, 
61.1, 50.3, 44.5, 42.7, 39.8, 28.9, 21.5, 14.2; HRMS (ES) 
Found MNa+ 572.0706. C25H28
79BrNNaO6S requires MNa
+ 
572.0718; LRMS m/z (ES) 574 (96%), 572 (100%); Found C, 
54.65; H, 4.91; N, 2.40; Br, 14.62; S, 5.88, C25H28BrNO6S 
requires C, 54.55; H, 5.13; N, 2.54; Br, 14.52; S, 5.82. For X-
ray data, see CCDC 1025236 [Monoclinic, Unit cell 
dimensions: a 19.1472(17), b 5.7177(5), c 22.9157(19), 
Volume 2484.3(4) Å3, T = 150 K, P21/n, Z = 4]. 
 
tert-Butyl 4-{1-Hydroxy-3-[(4-
methoxyphenyl)methoxy]propan-2-yl}-3-
methylidenepiperidine-1-carboxylate 26 
p-Methoxybenzyl alcohol (5.57 mL, 20 mmol) was added to a 
suspension of NaH (0.62 g, 20 mmol) in Et2O (15 mL) at room 
temperature. After 30 min, the mixture was cooled to 0 °C and 
Cl3CCN (4.30 mL, 20 mmol) was added. The mixture was 
allowed to warm to room temperature. After 4 h, the solvent 
was evaporated. Petrol (30 mL) and MeOH (0.5 mL) were 
added, the mixture was filtered through celite and the solvent 
was evaporated to give the crude trichloroacetimidate. To this 
was added CH2Cl2 (35 mL), the alcohol 23 (3.1 g, 10 mmol) 
and CSA (0.3 g, 1.0 mmol) at room temperature. After 18 h, the 
saturated aqueous NaHCO3 (15 mL) was added and the mixture 
was extracted with Et2O (3 × 30 mL). The organic layers were 
washed with water and purified by column chromatography on 
silica, eluting with petrol–EtOAc (9:1), to give the ester 26 
(3.51 g, 82%) as an oil; Rf 0.50 [petrol–EtOAc 9:1]; νmax 
(neat)/cm–1 2990, 2935, 1725, 1695, 1610; 1H NMR (400 MHz, 
CDCl3) δ = 7.21 (2H, d, J 8), 6.89 (2H, d, J 8), 4.96 (1H, s), 
4.83 (1H, s), 4.44 (1H, d, J 11.5), 4.39 (1H, d, J 11.5), 4.20 
(2H, q, J 7), 3.81 (3H, s), 3.70–3.66 (1H, m), 3.64–3.59 (2H, 
m), 3.50 (1H, dd, J 9, 4.5), 3.40–3.33 (1H, m), 3.09–3.01 (1H, 
m), 2.59–2.51 (1H, m), 1.76–1.65 (1H, m), 1.57–1.46 (2H, m), 
1.45 (9H, s), 1.27 (3H, t, J 7); 13C NMR (100 MHz, CDCl3, 
some peaks could not be observed) δ = 159.3, 154.8, 144.0, 
129.9, 129.3, 113.9, 111.6, 79.6, 73.3, 72.5, 65.8, 63.7, 55.3, 
38.8, 38.6, 28.4, 28.3, 15.3; HRMS (ES) Found MH+ 434.2538. 
C24H36NO6 requires MH
+ 434.2543; LRMS m/z (ES) 456 
(100%, MNa+). 
 
tert-Butyl 4-{1-Iodo-3-[(4-methoxyphenyl)methoxy]propan-
2-yl}-3-methylidenepiperidine-1-carboxylate 27 
Imidazole (0.18 g, 2.8 mmol) and iodine (0.67 g, 2.8 mmol) 
were added to PPh3 (0.74 g, 2.8 mmol) in CH2Cl2 (15 mL). 
After 10 min, the alcohol 17a (1.0 g, 2.55 mmol) in CH2Cl2 (5 
mL) was added. After 5 min, the mixture was filtered through 
celite, washed with EtOAc (3 × 15 mL) and evaporated. 
Purification by column chromatography, eluting with petrol–
EtOAc (9:1), gave the iodide 27 (1.24 g, 95%) as an oil; Rf 0.40 
(petrol–EtOAc 9:1); νmax (neat)/cm
–1 2970, 2925, 2855, 1695, 
1650, 1610, 1585; 1H NMR (400 MHz, CDCl3) δ = 7.27 (2H, d, 
J 8.5), 6.90 (2H, d, J 8.5), 4.99 (1H, m), 4.81 (1H, s), 4.44 (2H, 
s), 3.97 (1H, d, J 14), 3.83 (3H, s), 3.82–3.76 (1H, m), 3.67 
(1H, dd, J 10, 2.5), 3.52–3.47 (2H, m), 3.41–3.31 (2H, m), 3.22 
(1H, dd, J 10, 5.5), 2.33–2.28 (1H, m), 1.78–1.71 (2H, m), 
1.62–1.55 (1H, m), 1.47 (9H, s); 13C NMR (100 MHz, CDCl3) 
δ = 159.2, 154.7, 143.5, 130.3, 129.3, 113.8, 111.9, 79.7, 73.0, 
70.6, 55.3, 42.0, 40.8 (br), 37.8, 28.4, 27.7, 10.4; HRMS (ES) 
!∀#∃%&∋( ;−4<+21(=(>2.9.?810?<−(%7892≅,−Α(
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Found MNa+ 524.1262. C22H32NO4INa requires MNa
+ 
524.1274; LRMS m/z (ES) 524 (100%). 
 
tert-Butyl 4-{1-[2-(Ethoxycarbonyl)-1,3-dithian-2-yl]-3-[(4-
methoxyphenyl)methoxy]propan-2-yl}-3-
methylidenepiperidine-1-carboxylate 28 
To a solution of ethyl 1,3-dithiane-2-carboxylate (0.80 mL, 
5.08 mmol) in THF (20 mL) at –78 °C was added nBuLi (2.0 
mL, 5.08 mmol, 2.5 M in hexane) and HMPA (CAUTION, 
toxic) (3.1 mL, 17.6 mmol). After 10 min, the mixture was 
warmed to –40 °C, and the iodide 27 (2.0 g, 4.0 mmol) in THF 
(10 ml) was added. The mixture was allowed to warm to room 
temperature. After 24 h, water (40 mL) was added and the 
mixture was extracted with EtOAc (4 × 40 mL), dried 
(MgSO4), evaporated, and purified by column chromatography, 
eluting with petrol–EtOAc (9:1), to give ester 28 (1.8 g, 80%) 
as an oil; Rf  0.38 (petrol–EtOAc, 8:2); νmax (neat)/cm
–1 3065, 
2970, 2865, 1720, 1695, 1610, 1585; 1H NMR (400 MHz, 
CDCl3) δ = 7.25 (2H, d, J 8), 6.88 (2H, d, J 8), 4.97 (1H, s), 
4.92 (1H, s), 4.34 (2H, s), 4.21 (2H, q, J 7), 3.95 (1H, d, J 14), 
3.82 (3H, s), 3.79–3.75 (2H, m), 3.57–3.50 (1H, m), 3.46–3.41 
(2H, m), 3.37–3.30 (1H, m), 3.19–3.12 (1H, m), 2.72–2.67 (2H, 
m), 2.53–2.32 (3H, m), 2.15–2.02 (2H, m), 1.93–1.83 (1H, m), 
1.71–1.63 (2H, m), 1.47 (9H, s), 1.31 (3H, t, J 7); 13C NMR 
(100 MHz, CDCl3) δ = 171.1, 159.1, 154.8, 144.0, 130.6, 129.2, 
113.6, 111.7, 79.4, 72.6, 70.7, 69.5, 62.0, 55.3, 53.8, 42.3, 41.3 
(br), 37.0, 34.4, 28.5, 28.2, 27.3, 24.4, 14.1; HRMS (ES) Found 
MH+ 566.2604. C29H44NO6S2 requires MH
+ 566.2610; LRMS 
m/z (ES) 588 (100%), 566 (92%). 
 
tert-Butyl 4-{1-[2-(Hydroxymethyl)-1,3-dithian-2-yl]-3-[(4-
methoxyphenyl)methoxy]propan-2-yl}-3-
methylidenepiperidine-1-carboxylate 29 
LiAlH4 (1.40 mL, 2.78 mmol, 2.0 M in THF) was added to the 
ester 28 (1.45 g, 2.57 mmol) in THF (40 mL) at –5 °C. After 40 
min, the EtOAc (20 mL) and then saturated aqueous Na2SO4 
were added until a white salt precipitated. After 15 min, the 
mixture was filtered through celite, evaporated and purified by 
column chromatography, eluting with petrol–EtOAc (1:1), to 
give the alcohol 29 (1.15 g, 85%); alternatively, using LiAlH4 
(37.5 mg, 0.95 mmol) with the ester 28 (500 mg, 0.88 mmol) 
gave the alcohol 29 (440 mg, 93%) as an oil; Rf  0.39 (petrol–
EtOAc, 1:1); υmax (neat)/cm
–1 3450, 3075, 2930, 2855, 1685, 
1610, 1580; 1H NMR (400 MHz, CDCl3) δ = 7.25 (2H, d, J 8), 
6.88 (2H, d, J 8), 4.95 (1H, br s), 4.86 (1H, s), 4.38 (2H, s), 
4.10–3.90 (1H, m), 3.83 (3H, s), 3.79 (2H, s), 3.74–3.64 (1H, 
m), 3.54–3.47 (4H, m), 3.00–2.91 (2H, m), 2.77–2.69 (1H, br 
s), 2.63–2.59 (2H, m), 2.40–2.36 (1H, m), 2.29–2.23 (1H, m), 
2.13–2.07 (1H, m), 2.03–1.98 (1H, m), 1.88–1.75 (3H, m), 
1.72–1.63 (1H, m), 1.47 (9H, s); 13C NMR (100 MHz, CDCl3) 
δ = 159.2, 154.8, 144.4, 130.2, 129.4, 113.7, 111.8, 79.4, 72.8, 
72.0, 63.4, 55.3, 54.7, 43.8, 37.2, 33.7, 28.5, 26.0, 25.9, 24.8; 
HRMS (ES) Found MH+ 524.2484. C27H41NO5S2 requires MH
+ 
524.2504; LRMS m/z (ES) 546 (38%), 524 (100%). 
 
tert-Butyl 4-{5-Hydroxy-4,4-dimethoxy-1-[(4-
methoxyphenyl)methoxy]pentan-2-yl}-3-
methylidenepiperidine-1-carboxylate 30 
The alcohol 29 (1.15 g, 2.20 mmol) in THF (10 mL) was added 
to AgNO3 (1.70 g, 5.17 mmol), 2,4,6-collidine (2.33 mL, 17.6 
mmol) and N-chlorosuccinimide (1.15 g, 8.80 mmol) in THF 
(20 mL) and MeOH (30 mL) at 0 °C. After 1 h, saturated 
aqueous Na2CO3 (15 mL) and brine (15 mL) were added and 
the mixture was filtered through celite, washed with CH2Cl2, 
dried (MgSO4), evaporated and purified by column 
chromatography, eluting with petrol–EtOAc (6:4), to give 
alcohol 30 (0.52 g, 49%) as an oil; Rf 0.64 (petrol–EtOAc, 1:1); 
υmax (neat)/cm
–1 3450, 2970, 2930, 2860, 1690, 1610, 1590; 1H 
NMR (400 MHz, CDCl3) δ = 7.26–7.24 (2H, m), 6.91–6.88 
(2H, m), 4.94 (1H, s), 4.86 (1H, s), 4.44–4.38 (2H, m), 4.00–
3.98 (1H, m), 3.82 (3H, s), 3.73–3.70 (1H, m), 3.65–3.55 (2H, 
m), 3.49–3.45 (2H, m), 3.40–3.34 (1H, m), 3.22 (6H, s), 3.04 
(1H, s), 2.55 (1H, s), 2.35–2.31 (2H, m), 2.20 (1H, br s), 1.80–
1.76 (2H, m), 1.67–1.63 (1H, m), 1.47 (9H, s); 13C NMR (100 
MHz, CDCl3) δ = 160.0, 154.8, 143.4, 129.6, 129.3, 113.8, 
111.5, 102.4, 79.5, 73.1, 71.9, 70.3, 58.6, 54.3, 48.3, 48.1, 43.9, 
32.7, 31.9, 31.5, 28.4, 27.2; HRMS (ES) Found MNa+ 
502.2749, C26H41NO7Na requires MNa
+ 502.2724; LRMS m/z 
(ES) 502 (100%). 
 
tert-Butyl 4-{4,4-Dimethoxy-1-[(4-methoxyphenyl)methoxy]-
5-oxopentan-2-yl}-3-methylidenepiperidine-1-carboxylate 
31 
DMSO (0.14 mL, 1.99 mmol) in CH2Cl2 (1 mL) was added to 
oxalyl chloride (0.084 mL, 0.99 mmol) in CH2Cl2 (4 mL) at –
60 °C. After 10 min, alcohol 30 (0.40 g, 0.83 mmol) in CH2Cl2 
(1.5 mL) was added. After 10 min, Et3N (0.52 mL, 3.73 mmol) 
was added and the mixture was allowed to warm to room 
temperature. After 1 h, CH2Cl2 (5 mL) and water (5 mL) were 
added and the mixture was filtered through celite, washed with 
CH2Cl2 (3 × 10 mL), dried (MgSO4), evaporated and purified 
by column chromatography, eluting with petrol–EtOAc (7:3), 
to give aldehyde 31 (0.32 g, 80%) as an oil; Rf 0.79 (petrol–
EtOAc 1:1); υmax (neat)/cm
–1 2975, 2930, 2860, 2835, 1745, 
1690, 1645, 1610, 1585; 1H NMR (400 MHz, CDCl3) δ = 9.33 
(1H, s), 7.24 (2H, d, J 8), 6.88 (2H, d, J 8), 4.96 (1H, br s), 4.78 
(1H, s), 4.26 (2H, s), 4.00–3.92 (1H, m), 3.82 (3H, s), 3.70 (1H, 
d, J 14), 3.44–3.39 (2H, m), 3.31 (3H, s), 3.25 (3H, s), 2.46–
2.42 (1H, m), 1.99–1.87 (3H, m), 1.71–1.59 (4H, m), 1.47 (9H, 
s); 13C NMR (100 MHz, CDCl3) δ = 198.7, 160.4, 154.6, 143.3, 
129.6, 129.3, 113.9, 111.2, 102.2, 79.4, 72.8, 71.3, 55.5, 54.3, 
49.7, 49.6, 43.6, 41.3, 32.7, 30.5, 28.5, 27.8; HRMS (ES) 
Found MNa+ 500.2649. C26H39NO7Na requires MNa
+ 
500.2624; LRMS m/z (ES) 500 (100%) 478 (10%). 
 
2-tert-Butyl 9-Ethyl 7-Methoxy-5-{[(4-
methoxyphenyl)methoxy]methyl}-8-(prop-2-en-1-yl)-
1H,2H,3H,4H,5H,7aH,8H,9H,10H,10bH-pyrrolo[2,3-
j]isoquinoline-2,9-dicarboxylate 32 
N-Allylglycine ethyl ester hydrochloride salt (0.23 g, 1.26 
mmol), the aldehyde 31 (300 mg, 0.63 mmol) and iPr2NEt (0.22 
;−4<+21(=(>2.9.?810?<−(%7892≅,−Α( !∀#∃%&∋(
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mL, 1.26 mmol) in toluene (5 mL) were heated under reflux 
with a Dean–Stark trap. After 2 d, the solvent was evaporated 
and the residue was purified by column chromatography, 
eluting with petrol–EtOAc (4:1), to give the cycloadduct 32 
(140 mg, 38%) as an oil; Rf 0.14 (petrol–EtOAc, 4:1); υmax 
(neat)/cm–1 2930, 2860, 1730, 1690, 1610, 1590; 1H NMR (400 
MHz, CDCl3) δ = 7.26 (2H, d, J 8), 6.90 (2H, d, J 8), 5.86–5.73 
(1H, m), 5.08 (1H, br d, J 17), 4.96 (1H, br d, J 10), 4.83 (1H, 
br s, vinyl ether CH), 4.52–4.44 (2H, ABq), 4.14 (2H, q, J 7), 
3.95–3.87 (1H, br m), 3.82 (3H, s), 3.71 (1H, dd, J 9, 4), 3.67–
3.52 (2H, m), 3.52 (3H, s), 3.38–3.25 (3H, m), 2.90–2.73 (2H, 
m), 2.62–2.58 (1H, m), 2.19–2.11 (1H, m), 1.90–1.45 (5H, m), 
1.43 (9H, s), 1.27 (3H, t, J 7); 13C NMR (100 MHz, CDCl3, 
data from JMOD and HSQC) δ = 174.4 (C=O), 159.2 (C), 
155.0 (C=O), 153.2 (Cvinyl ether), 136.7 (CH), 130.4 (C), 129.1 
(CH), 115.9 (CH2), 113.8 (CH), 97.4 (CHvinyl ether), 79.3 (C), 
74.7 (CH2), 72.8 (CH2), 64.2 (CH), 61.6 (CH), 60.1 (CH2), 55.2 
(CH3), 54.0 (CH3), 52.6 (CH2), ~49.0 (sometimes could discern 
very broad, possible NCH2), 45.0 (C), ~39.0 (sometimes could 
discern very broad, possible NCH2), 38.6 (CH2), 35.7 (CH), 
35.5 (CH), 28.4 (CH3), 23.7 (CH2), 14.3 (CH3); HRMS (ES) 
Found MH+ 571.3374. C32H47N2O7 requires MH
+ 571.3383; 
LRMS m/z (ES) 571 (100%). 
 
2-tert-Butyl 9-Ethyl 7,7-Dimethoxy-5-{[(4-
methoxyphenyl)methoxy]methyl}-dodecahydropyrrolo[2,3-
j]isoquinoline-2,9-dicarboxylate 33 
The aldehyde 31 (0.25 g, 0.52 mmol), glycine ethyl ester 
hydrochloride salt (0.15 g, 1.05 mmol) and iPr2NEt (0.18 mL, 
1.05 mmol) were heated in toluene (5 mL) were heated under 
reflux with a Dean–Stark trap. After 3 d, the solvent was 
evaporated and the residue was purified by column 
chromatography, eluting with petrol–EtOAc (3:2), to give the 
cycloadduct 33 (0.17 g, 60%) as an oil; Rf 0.10 (petrol–EtOAc 
3:2); υmax (neat)/cm
–1 3285, 2930, 1690, 1615; 1H NMR (400 
MHz, CDCl3) δ = 7.23 (2H, d, J 8.5), 6.88 (2H, d, J 8.5), 4.41 
(2H, q, J 7), 4.26–4.10 (2H, m), 4.05–3.78 (2H, m), 3.82 (3H, 
s), 3.58–3.30 (4H, m), 3.27 (3H, s), 3.21 (3H, s), 3.12–2.87 
(1H, m), 2.83–2.61 (1H, m), 2.41–1.95 (4H, m), 1.94–1.51 (4H, 
m), 1.46 (9H, s), 1.24 (3H, t, J 7); 13C NMR (100 MHz, CDCl3) 
δ = 174.5, 159.1, 154.8, 130.5, 129.0, 113.7, 100.4, 79.5, 72.7, 
72.5, 71.1, 61.3, 56.9, 55.3, 48.0, 47.6, 45.7, 40.9, 36.9, 32.0, 
31.7, 28.5, 23.9, 22.5, 20.8, 14.1; HRMS (ES) Found MH+ 
563.3304. C30H47N2O8 requires MH
+ 563.3332; LRMS m/z 
(ES) 563 (100%). 
 
tert-Butyl 4-[1-Ethoxy-3-(methoxymethoxy)-1-oxopropan-2-
yl]-3-methylidenepiperidine-1-carboxylate 34 
Chloromethyl methyl ether (0.44 mL, 5.76 mmol) was added to 
the alcohol 22 (1.50 g, 4.80 mmol) and diisopropyl ethylamine 
(6.33 mL, 6.24 mmol) in CH2Cl2 (25 mL) at 0 °C. After 1 h, 
H2O (20 mL) was added and the mixture was extracted with 
Et2O (2 × 30 mL). The organic layers were washed with 
aqeuous HCl (10 mL, 1 M) and brine (10 mL), dried (MgSO4) 
and evaporated. Purification by column chromatography, 
eluting with petrol–EtOAc (7:3), gave the ester 34 (1.47 g, 
86%) as an oil; Rf  0.69 (petrol–EtOAc, 3:2); νmax (neat)/cm
–1 
2930, 2860, 1735, 1695; 1H NMR (400 MHz, CDCl3) δ = 4.92 
(1H, s), 4.79 (1H, s), 4.59 (2H, s), 4.17–4.08 (2H, m), 3.99 (1H, 
d, J 14), 3.85–3.76 (2H, m), 3.73–3.68 (1H, m), 3.60–3.53 (1H, 
m), 3.42–3.34 (1H, m), 3.33 (3H, s), 2.99 (1H, td, J 7, 4), 2.65–
2.57 (1H, m), 1.81–1.73 (1H, m), 1.55–1.46 (1H, m), 1.44 (9H, 
s), 1.23 (3H, t, J 7); 13C NMR (100 MHz, CDCl3) δ = 173.4, 
154.6, 143.4, 111.2, 96.5, 79.6, 66.7, 60.5, 55.3, 46.7, 41.5 (br), 
40.7, 28.6, 28.4, 14.2; HRMS (ES) Found MH+ 358.2247. 
C18H32NO6 requires MH
+ 358.2230; LRMS m/z (ES) 358 
(50%), 302 (100%). 
 
tert-Butyl 4-[1-Hydroxy-3-(methoxymethoxy)propan-2-yl]-
3-methylidenepiperidine-1-carboxylate 35 
LiAlH4 (2.03 mL, 2.78 mmol, 2.0 M in THF) was added to the 
ester 34 (1.45 g, 4.06 mmol) in THF (40 mL) at –5 °C. After 40 
min, the EtOAc (20 mL) and then saturated aqueous Na2SO4 
were added until a white salt precipitated. After 15 min, the 
mixture was filtered through celite, evaporated and purified by 
column chromatography, eluting with petrol–EtOAc (3:2), to 
give the alcohol 35 (1.11 g, 87%) as an oil; Rf  0.23 (petrol–
EtOAc, 3:2); υmax (neat)/cm
–1 3430, 2925, 2860, 1690, 1670; 1H 
NMR (400 MHz, CDCl3) δ = 5.02 (1H, s), 4.88 (1H, s), 4.64 
(2H, ABq), 3.95 (1H, d, J 14), 3.86 (1H, d, J 14), 3.82 (1H, dd, 
J 10, 4), 3.75 (1H, dd, J 10, 4), 3.70 (1H, dd, J 10, 7), 3.65 (1H, 
dd, J 10, 7), 3.47 (2H, t, J 6), 3.39 (3H, s), 2.46–2.41 (1H, m), 
2.17–2.10 (2H, m), 1.79–1.70 (1H, m), 1.66–1.57 (1H, m), 1.47 
(9H, s); 13C NMR (100 MHz, CDCl3) δ = 155.0, 144.1, 111.4, 
96.8, 79.6, 67.8, 64.1, 55.5, 49.3, 41.3, 39.4, 39.1, 28.4, 28.3; 
HRMS (ES) Found MH+ 316.2112. C16H30NO5 requires MH
+ 
316.2124; LRMS m/z (ES) 316 (25%), 260 (100%). 
 
tert-Butyl 4-[1-(Methoxymethoxy)-3-[(4-
methoxyphenyl)methoxy]propan-2-yl]-3-
methylidenepiperidine-1-carboxylate 36 
To a solution of alcohol 35 (450 mg, 1.42 mmol) in CH2Cl2 (10 
mL) was added 4-methoxybenzyl 2,2,2-trichloroacetimidate 
(722 mg, 2.55 mmol) and CSA (33 mg, 0.14 mmol) at room 
temperature. After 24 h, saturated aqueous NaHCO3 (5 mL) 
was added and the mixture was extracted with Et2O (3 × 30 
mL). The organic layers were combined, washed with water, 
dried (MgSO4) and evaporated. Purification by column 
chromatography on silica, eluting with petrol–EtOAc (3:2), 
gave the ether 36 (490 mg, 80%) as an oil; Rf 0.60 (petrol–
EtOAc, 3:2); υmax (neat)/cm
–1 2930, 2835, 1615, 1515; 1H NMR 
(400 MHz, CDCl3) δ = 7.25 (2H, d, J 8.5), 6.89 (2H, d, J 8.5), 
4.96 (1H, s), 4.82 (1H, s), 4.61 (2H, s), 4.41 (2H, s), 3.88 (2H, 
s), 3.82 (3H, s), 3.72 (1H, dd, J 10, 3.5), 3.55 (1H, dd, J 10, 6), 
3.45–3.52 (2H, m), 3.37–3.45 (2H, m), 3.35 (3H, s), 2.40–2.49 
(1H, m), 2.15–2.24 (1H, m), 1.68–1.79 (1H, m), 1.55–1.66 (1H, 
m), 1.46 (9H, s); 13C NMR (100 MHz, CDCl3) δ = 159.1, 
154.8, 144.3, 130.6, 129.2, 113.7, 111.0, 96.7, 79.6, 72.8, 69.1, 
65.6, 55.3, 48.8, 41.4, 39.4, 38.2, 28.5, 28.1; HRMS (ES) 
Found MH+ 436.2692. C24H38NO6 requires MH
+ 436.2699; 
LRMS m/z (ES) 436 (100%). 
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